Author: Dr. David Lowemann

Half of Americans May Be Candidates for Ozempic

More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug semaglutide, a new analysis finds. Sold as Ozempic for treating diabetes and Wegovy to spur weight loss, the medication could be indicated for those two… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, […]

Published on November 19, 2024

Eat These Vegetables for Lower Blood Pressure

Three out of four Americans over the age of 60 have high blood pressure, also called hypertension. Often called the ‘silent killer,’ high blood pressure typically has no symptoms. Heart disease, sexual dysfunction, stroke, kidney failure and aneurysms can all be caused by… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., […]

Published on November 18, 2024

Beyond the Positivity Bias: The Processing and Integration of Self‐Relevant Feedback Is Driven by Its Alignment With Pre‐Existing Self‐Views

Abstract Our self-concept is constantly faced with self-relevant information. Prevailing research suggests that information’s valence plays a central role in shaping our self-views. However, the need for stability within the self-concept structure and the inherent alignment of positive feedback with the pre-existing self-views of healthy individuals might mask valence and congruence effects. In this study […]

Published on November 18, 2024